$2.17
0.125.85%
最終更新: Oct 23, 7:30 PM
Benzinga
Benzinga
Benzinga
土曜日, 10 24
Benzinga
© 2026 Benzinga | All Rights Reserved
PAVmed (PAVM) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.64 | $-0.71 | $-4.62 | $-6.00 |
| Actual | $-0.27 | $-1.17 | $-1.05 | $-0.60 |
| Surprise | +57.8% | -64.8% | +77.3% | +90.0% |
| Revenue | ||||
| Estimate | $48000 | $79200 | $25000 | $12500 |
| Actual | $33000 | $22000 | $52000 | $5000 |
| Surprise | -31.3% | -72.2% | +108.0% | -60.0% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.66 | $-0.64 | $-0.65 | $-0.65 |
| Revenue | ||||
| Consensus | $25000 | $144000 | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 14, 2026 | $-0.27 | $-0.64 | 57.8 % |
| Q1 | May 15, 2026 | $-1.17 | $-0.71 | -64.8 % |
| Q4 | Mar 30, 2026 | $-1.05 | $-4.62 | 77.3 % |
| Q3 | Nov 13, 2025 | $-0.60 | $-6.00 | 90.0 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 14, 2026 | $33.00K | $48.00K | -31.3 % |
| Q1 | May 15, 2026 | $22.00K | $79.20K | -72.2 % |
| Q4 | Mar 30, 2026 | $52.00K | $25.00K | 108.0 % |
| Q3 | Nov 13, 2025 | $5.00K | $12.50K | -60.0 % |